FDA panel unanimously backs expanding use of Amarin`s heart drug Vascepa
(Reuters Health)

A panel of experts to the U.S. FDA recommended allowing Amarin Corp Plc`s fish-oil derived drug to be used as an add-on therapy for reducing the chance of heart attacks and strokes in high-risk patients with cardiovascular disease.